NP Thyroid was recalled because testing found those lots were sub potent, according to the FDA, which essentially means the drugs were too weak to work properly.
Manufacturer Acella Pharmaceuticals said in a statement that it had received four reports of adverse events possibly related to this recall. The recall covers one lot of 15 milligram NP Thyroid tablets and one lot of 120 milligram tablets.
The announcement follows a similar recall a few weeks ago of certain thyroid medications, however, it was done for opposite reasons. Previously, certain thyroid medications were recalled for being “too potent” and resulting in hyperthyroidism and complications associated with it in certain patients.
The recent thyroid drug recall has come from Acella Pharmaceuticals, which is announced the recall of two lots of its NP Thyroid 15 and NP Thyroid 120 tablets over reason that it could be “sub-potent.” This means that the medications may not have the same levels of thyroid hormones as what has been specified on the labels and that’s why the patients may not benefit from it.
This is dangerous for hypothyroid patients who may suffer from complications and certain symptoms such as depression, hair loss, dry skin, fatigue, puffy face and swelling of the thyroid.
The company’s recall was highlighted by the FDA and it highlighted how Acella Pharmaceutical received reports of adverse events in four people and was linked to the drugs that have now been recalled.
Consumers of these two medicines from the same brand of thyroid medication can find the other identification details related to the batches on FDA’s website.
Earlier this month, another manufacturer recalled two other brands of thyroid medication after the FDA testing found the strength lacking. RLC Labs recalled 483 lots of Nature-Throid and WP Thyroid in all strengths. The company posted a full list of all the recalled lots online. At the time of that recall, Walmart put out a 68-page list of pharmacies that had either Nature-Throid or WP Thyroid, according to the Miami Herald.
In a risk statement from the FDA, the agency said that patients who are being treated for an underactive thyroid, known as hypothyroidism, and who received a sub potent NP Thyroid prescription, could “experience signs and symptoms of hypothyroidism, which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight.”
In May, Acella Pharmaceuticals also issued a voluntary nationwide recall of 13 lots of NP Thyroid tablets due to what the FDA called a super potency. In that recall, the FDA said the drugs were recalled because the products had “up to 115.0% of the labeled amount of Liothyronine.”
At that time, the FDA warned that patients being treated for underactive thyroid and who received a super potent NP Thyroid prescription could experience hyperthyroidism, or an overactive thyroid.